[Established and new therapeutic approaches in dermatomyositis, polymyositis and overlapping syndromes]

I Göttfried; A Seeber; B Anegg; D Pirkhammer; A Rieger; G Stingl; B Volc-Platzer

[Established and new therapeutic approaches in dermatomyositis, polymyositis and overlapping syndromes]

Wien Klin Wochenschr. 1996 Nov 29;108(22):705-16.

[Article in German]

Authors

I Göttfried¹, A Seeber, B Anegg, D Pirkhammer, A Rieger, G Stingl, B Volc-Platzer

Affiliation

¹ Abteilung für Immundermatologie und Infektiöse Hautkrankheiten, Universität Wien.

PMID: 9157716

Abstract

An overview is presented on current antiinflammatory, cytostatic/cytotoxic and immunomodulatory treatments for immunologically mediated inflammatory myopathies with skin involvement. High-dose intravenous immunoglobulin (IVIG) therapy is discussed in the context of recent findings regarding pathogenic mechanisms of autoimmune diseases.

Publication types

English Abstract
Review

MeSH terms

Anti-Inflammatory Agents / therapeutic use
Blood Component Removal
Combined Modality Therapy
Dermatomyositis / immunology
Dermatomyositis / therapy*
Glucocorticoids / therapeutic use
Humans
Immunization, Passive
Immunosuppressive Agents / therapeutic use
Photopheresis
Polymyositis / immunology
Polymyositis / therapy*
Steroids

Substances

Anti-Inflammatory Agents
Glucocorticoids
Immunosuppressive Agents
Steroids